David Fogelman, MD

Pediatric Rehabilitation Medicine Doctor, Orthopedics and Sports Medicine Department
Instructor in Physical Medicine and Rehabilitation, Harvard Medical School
David Fogelman, MD
Phone 617-355-6021
Fax 617-730-0459
Email Email Me
NPI 1134440399
Print Profile
Request an Appointment
Locations

David Fogelman, MD

Pediatric Rehabilitation Medicine Doctor, Orthopedics and Sports Medicine Department
Instructor in Physical Medicine and Rehabilitation, Harvard Medical School

Medical Services

Programs & Services
Cerebral Palsy and Spasticity Center
Pediatric Rehabilitation Medicine Program
Orthopedics and Sports Medicine
Conditions & Treatments
Cerebral Palsy
AP 4 Associated Hereditary Spastic Paraplegia
Hereditary Spastic Paraplegia
Languages
English
Education
Medical School
Mount Sinai School of Medicine
2009
New York
NY
Internship
Columbia University, St. Luke’s-Roosevelt Hospital Center
2010
New York
NY
Residency
Spaulding Rehabilitation Hospital
2013
Boston
MA
Fellowship
Rehabilitation Institute of Chicago
2015
Chicago
IL
Media
Caregiver Profile

Meet Dr. David Fogelman

Certifications
American Board of Physical Medicine and Rehabilitation (General)
American Board of Physical Medicine and Rehabilitation (Pediatric Rehabilitation Medicine)
Professional History

David Fogelman, MD began his professional career in engineering school and learned a lot about how to look at the world in terms of cause and effect. He worked in R&D for a Fortune 500 technology company for a few years after college before leaving the field for medical school. Having an engineer’s mind and a doctor’s training really helps him efficiently find what he can do best for his patients and colleagues.

Approach to Care
Most people, no matter how many physicians they need to see, spend an overwhelming majority of their time working, playing, and living their lives outside of the doctor’s office. As a practitioner of Physical Medicine and Rehabilitation, I am responsible for helping my patients define their relationships with their lives outside of the time they spend in my direct care.

It is an honor, a privilege, and above all a great adventure to work with children and adolescents with special needs. Underlying all that I do is the fundamental belief that all kids of any age and any level of ability deserve the opportunity to laugh, play, and cause some trouble. I know I can help with that.

Publications

Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley. View Abstract
Association between lower limb spasticity and cryptorchidism in males with cerebral palsy. View Abstract
Mendelian etiologies identified with whole exome sequencing in cerebral palsy. View Abstract
Exercise to enhance neurocognitive function after traumatic brain injury. View Abstract
Exercise, sports participation, and musculoskeletal disorders of pregnancy and postpartum. View Abstract
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer. View Abstract
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. View Abstract
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. View Abstract
Emerging drugs for colorectal cancer. View Abstract
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. View Abstract
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. View Abstract
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. View Abstract
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis. View Abstract
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy. View Abstract
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. View Abstract
Locations